Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY

Ferguson JJ, Mahaffey KW, Huang Y, Armstrong P, Levine G, Kleiman NS, Goodman SG, Cohen M, Antman E, Califf RM. Enoxaparin versus unfractionated heparin: consequences of treatment duration on efficacy and safety in SYNERGY. Journal of the American College of Cardiology. 2005; 45(Suppl1):247A.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.